revealtrial.org Report : Visit Site

Technical data of the revealtrial.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host revealtrial.org. Currently, hosted in United Kingdom and its service provider is Oxford University .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips mod_auth_gssapi/1.5.1 mod_fcgid/2.3.9 mod_nss/1.0.14 NSS/3.28.4 PHP/5.4.16 mod_wsgi/3.4 Python/2.7.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

 hps3/timi55- randomized evaluation of the effects of anacetrapib through lipid-modification information for participants -- home about downloads & faqs results contact about our study welcome to the study website the study is an international clinical trial that aims to find out if treating cholesterol with a new drug called anacetrapib will drive down the risk of heart attacks, deaths from heart disease and other vascular diseases. the results of the trial were announced at the european society of cardiology congress in barcelona on tuesday 29th august 2017 and were simultaneously published in the new england journal of medicine . you may read or download a copy of the paper from http://www.nejm.org/doi/full/10.1056/nejmoa1706444 . the results are summarised in our press release, which is available to download here . what does the study involve? involves over 30,000 men and women who already have some form of circulatory disease. participants were recruited from over 430 hospitals and clinics in the uk, north america, china, germany, italy and scandinavia. all study participants were given atorvastatin (a commonly used "statin" drug) to ensure good control of ldl ("bad") cholesterol. participants also received either anacetrapib or matching placebo (dummy) tablets daily (allocated randomly). the primary aim of the study is to see whether fewer participants given anacetrapib have heart attacks, revascularization procedures or die from coronary heart disease than do those given the placebo tablets. all participants stopped study treatment prior to february 2017. however further follow-up, off study treatment, is continuing for several years. downloads the following downloads are available: slides presented at the aha scientific sessions - november 2017 slides presented at the aha scientific sessions - november 2017 results press release - august 2017 results esc presentation slides - august 2017 see the results section for a link to the main results paper published in august 2017 baseline paper - may 2017 data analysis plan v1.1 - may 2017 data analysis plan v1.0 - june 2016 uk participant newsletter - issue 3, spring 2016 uk participant newsletter - issue 2, summer 2015 uk participant newsletter - issue 1, spring 2014 frequently asked questions what is the purpose of the study? who is running and who is funding the study? where is the trial registered? what if there is a problem? what is the purpose of the study? the study is called the trial. it is investigating whether the drug anacetrapib (a cetp inhibitor) in combination with a statin can prevent vascular disease in high risk patients. is the largest study looking into the possible benefits of boosting good cholesterol and further lowering bad cholesterol to prevent heart attacks and strokes in people who have suffered these conditions before, and who are already taking statins. this means that is uniquely positioned to answer questions about the contribution of good and bad cholesterol on the risk of serious cardiovascular diseases. ^back to faq who is running and who is funding the study? the clinical trial service unit ( ctsu ) in the nuffield department of population health ( ndph ) at the university of oxford is coordinating this study and has overall responsibility for the administration and coordination of the study. there is a steering committee to oversee the trial conduct and an independent data monitoring committee perform regular analyses on data collected so far to check that the study tablets aren't causing any illness. funding for this study is provided by merck sharp & dohme corp. to cover the administrative and coordination costs of the trial. the university of oxford is acting as the sponsor of this study. ^back to faq where is the trial registered? the trial is registered with the following bodies: • isrctn (international standard randomised controlled trial number): 48678192 • clinicaltrials.gov: nct01252953 • eu clinical trials register: 2010-023467-18 • ukcrn (uk clinical research network): 10598 ^back to faq what if there is a problem? if you have any concerns about any possible side-effects of treatment or any complaint about the way you have been dealt with during the study, please call the study team on freefone 0800­ 585­ 323 (uk). ^back to faq results the results of the trial were announced at the european society of cardiology congress in barcelona at 07:30 british summer time on tuesday 29th august 2017 and were simultaneously published in the new england journal of medicine . you can read or download a copy of the paper from http://www.nejm.org/doi/full/10.1056/nejmoa1706444 . the results are summarised in our press release, which is available to download here . to view adverse events and reactions by meddra classification click on this link . contact (uk) 24-hour freefone service: 0800­ 585 323 by post: , clinical trial service unit (ctsu), richard doll building, university of oxford, roosevelt drive, oxford, ox3 7lf by email: @ndph.ox.ac.uk clinical trial service unit (ctsu) website: https://www.ctsu.ox.ac.uk medical research council population health research unit (mrc phru) website: https://www.mrc-phru.ox.ac.uk © ctsu, richard doll building, old road campus, roosevelt drive, oxford, ox3 7lf, uk. telephone: +44 (0)1865 743743; fax: +44 (0)1865 743985. this website was last updated on 15th december 2017

URL analysis for revealtrial.org

http://www.revealtrial.org/#faq5
http://www.revealtrial.org/#ptinfo
http://www.revealtrial.org/revealparticipantnewsletter_issue_2_summer2015_uk.pdf
http://www.revealtrial.org/revealparticipantnewsletter_issue_1_spring2014_uk.pdf
http://www.revealtrial.org/#home
http://www.revealtrial.org/#contact
http://www.revealtrial.org/#faq1
http://www.revealtrial.org/#about
http://www.revealtrial.org/reveal_aha_dm_2017-11-13.pdf
http://www.revealtrial.org/reveal_results_press_release_2017-08-29.pdf
http://www.revealtrial.org/reveal_results_slides_2017-08-29.pdf
http://www.revealtrial.org/reveal_aha_rec_events_2017-11-13.pdf
http://www.revealtrial.org/revealparticipantnewsletter_issue_3_spring2016_uk.pdf
http://www.revealtrial.org/#results
http://www.revealtrial.org/#faq2
ndph.ox.ac.uk
ctsu.ox.ac.uk
mrc-phru.ox.ac.uk
ox.ac.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: REVEALTRIAL.ORG
Registry Domain ID: D160616342-LROR
Registrar WHOIS Server:
Registrar URL: http://www.tucows.com
Updated Date: 2015-08-11T21:14:13Z
Creation Date: 2010-11-08T15:04:17Z
Registry Expiry Date: 2020-11-08T15:04:17Z
Registrar Registration Expiration Date:
Registrar: Tucows Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: C156185888-LROR
Registrant Name: IT Services Domain Registration
Registrant Organization: University of Oxford
Registrant Street: IT Services
Registrant Street: 7-19 Banbury Road
Registrant City: Oxford
Registrant State/Province:
Registrant Postal Code: OX2 6NN
Registrant Country: GB
Registrant Phone: +44.1865273619
Registrant Phone Ext:
Registrant Fax: +44.1865273275
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID: C156185889-LROR
Admin Name: IT Services Domain Registration
Admin Organization: University of Oxford
Admin Street: IT Services
Admin Street: 7-19 Banbury Road
Admin City: Oxford
Admin State/Province:
Admin Postal Code: OX2 6NN
Admin Country: GB
Admin Phone: +44.1865273619
Admin Phone Ext:
Admin Fax: +44.1865273275
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID: C156185018-LROR
Tech Name: IT Services Hostmaster
Tech Organization: University of Oxford
Tech Street: IT Services
Tech Street: 7-19 Banbury Road
Tech City: Oxford
Tech State/Province:
Tech Postal Code: OX2 6NN
Tech Country: GB
Tech Phone: +44.1865273600
Tech Phone Ext:
Tech Fax: +44.1865273275
Tech Fax Ext:
Tech Email: [email protected]
Name Server: DNS0.OX.AC.UK
Name Server: DNS2.OX.AC.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-09-17T00:49:54Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS revealtrial.org

  PORT 43

  TYPE domain

DOMAIN

  NAME revealtrial.org

  HANDLE D160616342-LROR

  CREATED 2010-08-11

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  DNS0.OX.AC.UK 129.67.1.190

  DNS2.OX.AC.UK 163.1.2.190

OWNER

  HANDLE C156185888-LROR

  NAME IT Services Domain Registration

  ORGANIZATION University of Oxford

ADDRESS

STREET
IT Services
7-19 Banbury Road

  CITY Oxford

  PCODE OX2 6NN

  COUNTRY GB

  PHONE +44.1865273619

  EMAIL [email protected]

ADMIN

  HANDLE C156185889-LROR

  NAME IT Services Domain Registration

  ORGANIZATION University of Oxford

ADDRESS

STREET
IT Services
7-19 Banbury Road

  CITY Oxford

  PCODE OX2 6NN

  COUNTRY GB

  PHONE +44.1865273619

  EMAIL [email protected]

TECH

  HANDLE C156185018-LROR

  NAME IT Services Hostmaster

  ORGANIZATION University of Oxford

ADDRESS

STREET
IT Services
7-19 Banbury Road

  CITY Oxford

  PCODE OX2 6NN

  COUNTRY GB

  PHONE +44.1865273600

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .